tetramethylammonium has been researched along with naloxone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hough, C; Mazorow, DL; Millar, DB | 1 |
1 other study(ies) available for tetramethylammonium and naloxone
Article | Year |
---|---|
The K channel blocker, tetraethylammonium, displaces beta-endorphin and naloxone from T-cell binding sites.
Topics: beta-Endorphin; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Charybdotoxin; Electrophysiology; Mitogens; Naloxone; Narcotic Antagonists; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-myc; Quaternary Ammonium Compounds; T-Lymphocytes; Tetraethylammonium; Tetraethylammonium Compounds; Tumor Cells, Cultured | 1997 |